Pre-market
Loading markets…

Advertisement

Stocks

Curaleaf Holdings Inc. (CURA.TO) Slides 9% This Week Amid Market Headwinds

By Qayyum Rajan, CFA -

Follow live quotes and coverage.

Stocks & ETFs:CURA.TO

Follow CURA

Photos provided by Pexels

Curaleaf Holdings Inc. has faced a challenging week, dropping nearly 9% as rising bond yields and broader market concerns weigh on investor sentiment. The stock's performance highlights ongoing struggles in the cannabis sector.

Over the past week, Curaleaf Holdings Inc. (CURA.TO) has seen its stock price decline by approximately 9%, reflecting broader market pressures. With a current market cap of CA$3.32 billion, the company is grappling with negative earnings and a profit margin of -2.63%. Investors are increasingly cautious as rising bond yields continue to impact growth-oriented sectors, including cannabis.

Investor takeaway: Long-term investors should monitor Curaleaf's performance closely as it navigates a challenging market environment.

Advertisement

Curaleaf Holdings Inc.

CURA.TO

Full stock page →

CURA.TO

Curaleaf Holdings Inc.

Source:WealthAwesomeWealthAwesome
↓ $1.67 (-12.32%)
120 day period
$11.71$14.26$16.80Apr 24Jul 21Oct 15

Market cap

$3.15B

52W high

$20.93

52W low

$7.77

1W change

-11.93%

Beta

1.60

Analyst Price Targets

Based on analyst covering CURA · as of Oct 16, 2026

📈

Wall Street analysts forecast CURA stock price to rise 58.4% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$18.84

+58.4% Upside

Previously C$18.88 on Oct 15, 2026

Current Price

C$11.89

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CURA's historical volatility

HistoricalForecast68%95%
C$5.11C$8.27C$11.43C$14.60C$17.76C$20.93TodayJun 8Aug 12Oct 15Nov 27Jan 10Feb 22

30-Day Vol

56.5%

Annualized

90-Day Vol

56.1%

Annualized

Trend (90d)

-39.1%

Annualized drift

90d Mean

C$10.34

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$11.35C$9.34 – C$13.79
60 trading daysC$10.83C$8.22 – C$14.27
90 trading daysC$10.34C$7.38 – C$14.49

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

What the 9% Drop Means for Curaleaf's Valuation

The recent decline in Curaleaf's stock price brings its forward P/E ratio into sharper focus, currently sitting at 138.89x. This high valuation, combined with ongoing losses, raises concerns about the sustainability of its market position as investor confidence wanes.

Bull case

  • Curaleaf's strong market position might help it bounce back if the cannabis sector recovers.
  • Potential regulatory changes could improve industry dynamics in the future.
  • The company has growth opportunities as it expands its product offerings.

Bear case

  • Ongoing pressure from rising bond yields may further dampen investor sentiment.
  • Negative earnings and a high forward P/E ratio of 138.89x could deter new investments.
  • The cannabis sector faces significant challenges, including regulatory hurdles and market saturation.

Why Rising Bond Yields Are Hurting Curaleaf

Advertisement

The cannabis sector, including Curaleaf Holdings Inc., is particularly sensitive to rising bond yields, which can lead to higher borrowing costs and reduced investor appetite for growth stocks. As yields increase, investors often shift their focus to safer assets, leaving high-growth sectors like cannabis vulnerable to declines.

Curaleaf's Financial Struggles Amplified by Market Conditions

With a profit margin of -2.63% and a forward P/E ratio of 138.89x, Curaleaf's financials are under scrutiny. The company's negative earnings per share (EPS) further complicate its outlook, making it difficult for investors to justify its current valuation amid a declining stock price. The market's reaction suggests that investors are losing confidence in the company's ability to turn around its financial performance.

What Lies Ahead for Curaleaf and Cannabis Stocks

Looking forward, Curaleaf's performance will likely depend on broader market conditions and potential regulatory changes in the cannabis industry. Investors should keep an eye on upcoming earnings reports and any shifts in market sentiment that could impact the stock's recovery. The current environment presents both challenges and opportunities, making it essential for investors to stay informed.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 14, 2026
Last Updated: October 14, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement